Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Similares en
SciELO
Compartir
Revista Venezolana de Oncología
versión impresa ISSN 0798-0582
Resumen
PALACIOS F, Luis et al. Cirugía de intervalo citorreducción óptima en cáncer de ovario estadio III. Rev. venez. oncol. [online]. 2009, vol.21, n.2, pp.85-91. ISSN 0798-0582.
OBJECTIVE: To demonstrate that interval debulking surgery constitutes an effective therapeutic option in the increase of the tumor like resected, improving the over life of those patients with epithelial tumors of ovary classified III stage, catalogued like none resected. METHODS: Retrospective and descriptive study of the patients that assisted the service of gynecology of the Oncology Hospital Padre Machado with the diagnosis of epithelial tumor of ovary III stage, included in protocol interval debulking surgery, during the period September 2002 - September 2007. RESULTS: 13 patients were identified. The scheme of chemotherapy used in all the cases was paclitaxel at dose of 175mg/m2 and carboblatin 5ABC, with a media of 4.46 cycles. An answer greater than 50 % was settled down subsequent to the primary chemotherapy in a 76.92 % of the patients. CONCLUSIONS: The interval debulking surgery increases the percentage of respectability and diminishes the percentage of postoperative complications, not demonstrating itself significant benefits in terms of increase in the free disease period.
Palabras clave : Cancer; ovary; interval; resects; over life.












